glp 1 drugs for weight loss Comparing Ozempic, Wegovy and Other GLP-1 Oral GLP-1 Medication Helps Patients

Funding: Supported by NIH grants P30 DK056341 (Washington University Nutrition and Obesity Research Center), P30 DK020579 (Washington University Diabetes Research Center), UL1 TR000448 (Washington University Institute of Clinical and Translational Sciences), and T32 DK007120, and the Barnes-Jewish Hospital Foundation

Mol Metab 5 , 834843, (2016)

Okun The New England Journal of Medicines recent publication of a randomized study of a GLP-1 agonist originally designed for diabetes, but applied to Parkinson's disease, has led to a flurry of excitement and to a mountain of questions

Elevated levels of plasma cholesterol constitute the most important factor in the development of AS (113)

Bottom line GLP-1 medications, or glucagon-like peptide-1 receptor agonists, treat type 2 diabetes and, in some cases, obesity

Beyond Weight Loss : Early studies indicate significant cognitive enhancement, cardiovascular improvement, and reduced inflammationcore pillars of longevity